Anatomical Femoral Stem in Total Hip Arthroplasty

NCT04243980 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2020-01-28

No results posted yet for this study

Summary

A study that detect the femoral anteversion after total hip arthroplasty using short anatomical femoral stem compared to the contrast side

Conditions

  • Patient Compliance
  • Patient Satisfaction

Interventions

DEVICE

Short anatomical femoral stem in THR

Patients with osteoarthritis after total hip arthroplasty

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2021-01-01
Completion
2022-01-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04243980 on ClinicalTrials.gov